Atea Pharmaceuticals, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Other Events

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

2.02,9.01

Results of Operations and Financial Condition

2.02,9.01

5.07

2.02,9.01

2.02,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Automatic Shelf Registration

Prospectus Supplement with Pricing Information

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

No description available

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

06b

06b

06b

06b

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

BERGER FRANKLIN M

Berman Howard

DUNCAN BARBARA GAYLE

Adams Jerome M.

Polsky Bruce

Murphy Polly A.

KIRSCH ARTHUR S

Lucidi Bruno

Murphy Polly A.

Murphy Polly A.

FMR LLC

VANGUARD GROUP INC

Corcoran Andrea

BML Investment Partners, L.P.

Vavricka John

Horga Maria Arantxa

Foster Wayne

Sommadossi Jean-Pierre

Corcoran Andrea

Hammond Janet MJ

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Post-effective amendment to an automatic shelf registration statement

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

No description available

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)